Skip to content

Quality of Life Measures After Single Access Vs Conventional Laparoscopic Cholecystectomy: Prospective Randomized Study.

Single Access Laparoscopic Cholecystectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01412996
Enrollment
250
Registered
2011-08-09
Start date
2009-11-30
Completion date
2012-01-31
Last updated
2012-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evidence of Cholecystectomy

Brief summary

This study aimed to compare the short term outcomes between SALC and conventional laparoscopic cholecystectomy (CLC).

Detailed description

In a prospective study, two hundred fifty patients with symptomatic gall bladder stone were randomized to SALC or conventional laparoscopic cholecystectomy (CLC) (125 in each group). The primary endpoint of this study was to assess the total outcomes of quality of life using EuroQoL EQ-5D questionnaire. The secondary endpoints were postoperative pain, analgesia requirement and duration, operative time, perioperative complications, estimated blood loss, hospital stay, cosmoses outcomes and number of days required to return to normal activities.

Interventions

PROCEDUREsurgery

single ACCESS laparoscopic cholecystectomy

OTHERSURGERY

CONVENTIONAL LAPAROSCOPIC CGOLECYSTECTOMY

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* GALL BLADDER STONES

Exclusion criteria

* ACUTE CHOLECYSTITIS * PREVIOUS LAPAROTOMY * ASA ABOVE 3

Design outcomes

Primary

MeasureTime frameDescription
QUALITY OF LIFEPREOPERATIVEELY, after 1 WEEK, 1 and 6 months postoperativeQuality of life was the primary endpoint of this study assessed by EuroQoL EQ-5D 9 questionnaire preoperatively, 1 week, 1 and 6 months after surgery. The EQ-5D is a validated questionnaire which consists of 2 pages: the EQ-5D descriptive system and EQ visual analogue scale (EQ VAS). The WQ-5D-descriptive system consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems.

Secondary

MeasureTime frameDescription
operative time2 hours(defined as the interval between the initial skin incision and skin closure)
postoperative pain5 daysusing verbal analogue scale (VAS) from 0 to 10 (0 = no pain, 10 = severe pain)
days to return to normal activity (RTNA)10 dayspatients were contacted by phone every day until they are able to return to their normal daily works
COSMOSIS OUTCOMES1 AND 6 MONTHScosmetic outcomes 1 and 6 months after surgery using Patient and Observer Scar Assessment Scale (POSAS)(10), it comprises two distinct series of Visual Analogue Scale (VAS) instruments: one is self-assessed by the patient and one by an independent doctor, ranging from 1 (poor) to 10 (excellent)
ANALGESIC REQUIRMENTPOSTOPERATIVE PERIODNOMBERS OF ANALGESIC TABLETS AND NO. OF DAYS ANALGESIA NEEDED

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026